Closure of the patent ductus arteriosus with ligation and indomethacin: a consecutive experience.
This report summarizes a consecutive experience with 59 preterm infants with clinical, radiographic, and echocardiographic findings of a large patent ductus arteriosus. Thirty-five infants who met defined criteria received indomethacin, and 24 infants underwent PDA ligation. Analysis of the clinical course of these infants revealed no selective indomethacin morbidity and suggests that infants undergoing ligation require more prolonged ventilator therapy with increased exposure to FiO2 greater than or equal to 0.3. Mortality rates between ligated and pharmacologically treated groups were similar. This study documents that inhibition of prostaglandin synthesis to constrict and close the PDA in the premature infant is an effective alternative to operative closure.
D004374:Ductus Arteriosus, Patent / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D007231:Infant, Newborn; D008026:Ligation; D012127:Respiratory Distress Syndrome, Newborn / Q000150:complications / Q000628:therapy; D012122:Ventilators, Mechanical
D007213:Indomethacin